Seeing Is Believing

Currently out of the existing stock ratings of Michael Jungling, 13 are a BUY (76.47%), 1 are a SELL (5.88%), 3 are a HOLD (17.65%).
Analyst Michael Jungling, currently employed at BARCLAYS, carries an average stock price target met ratio of 23.33% that have a potential upside of 10.48% achieved within 146 days.
Michael Jungling’s has documented 34 price targets and ratings displayed on 6 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on FMS, Fresenius Medical Care at 24-Sep-2021.
Analyst best performing recommendations are on SNN (SMITH & NEPHEW SNATS).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 4/22/2020. The price target of $48.84 was fulfilled within 296 days with a profit of $13.55 (38.4%) receiving and performance score of 1.3.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Aug-2024
2 months 18 days ago
(06-Aug-2026)
7/13 (53.85%)
$-7.2 (-32.01%)
627
Hold Since 28-Feb-2024
2 months 19 days ago
(05-Aug-2026)
12/17 (70.59%)
$-8.4 (-37.35%)
305
Buy Since 20-Aug-2024
$35
$4.17 (13.53%)
$39
3 months 17 days ago
(07-Jul-2026)
0/3 (0%)
$4.52 (14.83%)
Hold Since 17-Mar-2025
$30
$-0.04 (-0.13%)
$35
5 months 13 days ago
(11-May-2026)
5/6 (83.33%)
$0.9 (3.09%)
16
Buy Since 29-Jan-2025
$37.5
$7.46 (24.83%)
1 years 10 days ago
(14-Oct-2025)
2/4 (50%)
$2.24 (6.35%)
762
What Year was the first public recommendation made by Michael Jungling?